Natco Pharma Ltd
NSE:NATCOPHARM

Watchlist Manager
Natco Pharma Ltd Logo
Natco Pharma Ltd
NSE:NATCOPHARM
Watchlist
Price: 830 INR -3.03% Market Closed
Market Cap: 148.7B INR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+34%
Revenue
Forecast
-2%
Operating Income
Forecast
-20%
Net Income
Forecast
-16%

Wall Street
Price Targets

NATCOPHARM Price Targets Summary
Natco Pharma Ltd

Wall Street analysts forecast NATCOPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 1 110.78 INR with a low forecast of 717.1 INR and a high forecast of 1 758.75 INR.

NATCOPHARM Lowest Forecast
Wall Street Target
717.1 INR
14% Downside
NATCOPHARM Average Forecast
Wall Street Target
1 110.78 INR
34% Upside
NATCOPHARM Highest Forecast
Wall Street Target
1 758.75 INR
112% Upside
Lowest
Price Target
717.1 INR
14% Downside
Average
Price Target
1 110.78 INR
34% Upside
Highest
Price Target
1 758.75 INR
112% Upside
Natco Pharma Ltd Competitors:
Price Targets
NWRN
Newron Pharmaceuticals SpA
102% Upside
I
IMP
Imexpharm Corp
6% Upside
F
FAE
Faes Farma SA
6% Upside
ROG
Roche Holding AG
11% Upside
NWRN
Newron Pharmaceuticals SpA
102% Upside
I
IMP
Imexpharm Corp
6% Upside
F
FAE
Faes Farma SA
6% Upside
ROG
Roche Holding AG
11% Upside
M
MOC
Molecure SA
119% Upside
4547
Kissei Pharmaceutical Co Ltd
8% Upside
S
SBBC
Simply Better Brands Corp
88% Upside

Revenue
Forecast

Revenue Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -2%.

18%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 28%. The projected CAGR for the next 3 years is -20%.

28%
Past Growth
-20%
Estimated Growth
Estimates Accuracy
-10%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Natco Pharma Ltd

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 31%. The projected CAGR for the next 3 years is -16%.

31%
Past Growth
-16%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

See Also

Summary
NATCOPHARM intrinsic value, competitors valuation, and company profile.
DCF Valuation
NATCOPHARM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NATCOPHARM stock valuation using valuation multiples.
Wall Street Estimates
NATCOPHARM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NATCOPHARM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NATCOPHARM's stock price target?
Price Target
1 110.78 INR

According to Wall Street analysts, the average 1-year price target for NATCOPHARM is 1 110.78 INR with a low forecast of 717.1 INR and a high forecast of 1 758.75 INR.

What is Natco Pharma Ltd's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's revenue is 18%. The projected CAGR for the next 3 years is -2%.

What is Natco Pharma Ltd's Operating Income forecast?
Projected CAGR
-20%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's operating income is 28%. The projected CAGR for the next 3 years is -20%.

What is Natco Pharma Ltd's Net Income forecast?
Projected CAGR
-16%

For the last 8 years the compound annual growth rate for Natco Pharma Ltd's net income is 31%. The projected CAGR for the next 3 years is -16%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.